Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Operating Activities
Net income including noncontrolling interests	$ 1,695	$ 1,924
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:
Depreciation and amortization	417	410
ERISA litigation matter	267	0
Restructuring and termination benefits, net of cash	(17)	51
Stock-based compensation expense	97	105
Gain on the sale of land	0	(47)
Deferred income taxes	(109)	(13)
Cash effects of changes in:
Receivables	(62)	(171)
Inventories	150	(422)
Accounts payable and other accruals	168	9
Other non-current assets and liabilities	3	37
Net cash provided by (used in) operations	2,609	1,883
Investing Activities
Capital expenditures	(508)	(475)
Purchases of marketable securities and investments	(324)	(239)
Proceeds from sale of marketable securities and investments	264	55
Payment for acquisitions, net of cash acquired	0	(817)
Proceeds from the sale of land	0	47
Other investing activities	(31)	1
Net cash provided by (used in) investing activities	(599)	(1,428)
Financing Activities
Short-term borrowing (repayment) less than 90 days, net	(564)	(56)
Principal payments of debt	(903)	(2)
Proceeds from issuance of debt	1,497	1,513
Dividends paid	(1,243)	(1,206)
Purchases of treasury shares	(883)	(895)
Proceeds from exercise of stock options	325	398
Other financing activities	(30)	(38)
Net cash provided by (used in) financing activities	(1,801)	(286)
Effect of exchange rate changes on Cash and cash equivalents	(33)	(63)
Net increase (decrease) in Cash and cash equivalents	176	106
Cash and cash equivalents at beginning of the period	775	832
Cash and cash equivalents at end of the period	951	938
Supplemental Cash Flow Information
Income taxes paid	726	690
Interest paid	$ 243	$ 104